MedTrace Logo

Management of Women With BRCA1/2 Mutation

NCT03211611 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2018-05-07

No results posted yet for this study

Summary

The aim of this study is to determine general practitionners' role in management of women with BRCA1/2 mutation.

This study will be conduct between April 2017 and December 2017 at Montpellier University Hospital on women followed-up in the department of genetics and their general practitionners (GP). Patients and their GP will be called by the investigators and questionnaire will be given to them. Questionnaire includes questions for patients and their GP. The primary endpoint was to determine the rate of GP having sufficient knowledge of the adequate management of patients with BRCA1 / 2 mutation. Adequate knowledge includes : systematic search for a family history of cancer, knowing criteria required to refer women in oncogenetic department, and the ability to respond to patients' questions. Secondary endpoint was to determine women' opinion on their GP : whether or not well managed for their BRCA 1 / 2 mutation.

Conditions

  • BRCA1 Mutation
  • BRCA2 Mutation

Interventions

BEHAVIORAL

Questionnaire given to the two groups

Questionnaire given to the two groups : Patients with BRCA ½ mutation GP

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Pascal PUJOL, PR · University Hospital, Montpellier

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2017-08-31
Completion
2017-11-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03211611 on ClinicalTrials.gov